News | October 07, 2023
Amgen completes acquisition of Horizon Therapeutics
Advances Amgen's mission to serve patients with rare disease medicines
Advances Amgen's mission to serve patients with rare disease medicines
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
New Board of Directors and management team at Suven Pharma also appointed
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Sets price band at ?695 to ?735 per Equity Share
Subscribe To Our Newsletter & Stay Updated
